Patents by Inventor Markus Imhof

Markus Imhof has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150252383
    Abstract: The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein the expression vector does not contain any complete gene of the mCMV.
    Type: Application
    Filed: May 20, 2015
    Publication date: September 10, 2015
    Inventors: PHILIPPE CHATELLARD, MARKUS IMHOF
  • Patent number: 9051582
    Abstract: The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein the expression vector does not contain any complete gene of the mCMV.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: June 9, 2015
    Assignee: MERCK SERONO SA
    Inventors: Philippe Chatellard, Markus Imhof
  • Patent number: 8133699
    Abstract: The invention relates to expression vectors comprising a DNA sequence of 146 bp capable of acting as chromatin insulator, to host cells containing such vectors, to a method of producing a desired polypeptide by using vectors containing said sequence and to the use of said DNA sequence.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: March 13, 2012
    Assignee: Merk Serono S.A.
    Inventors: Philippe Chatellard, Markus Imhof
  • Publication number: 20110008839
    Abstract: The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein the expression vector does not contain any complete gene of the mCMV.
    Type: Application
    Filed: August 31, 2010
    Publication date: January 13, 2011
    Applicant: MERCK SERONO SA
    Inventors: Philippe Chatellard, Markus Imhof
  • Patent number: 7824907
    Abstract: The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein expression vector does not contain any complete gene of the mCMV.
    Type: Grant
    Filed: March 10, 2004
    Date of Patent: November 2, 2010
    Assignee: Merck Serono SA
    Inventors: Philippe Chatellard, Markus Imhof
  • Publication number: 20080032300
    Abstract: This invention relates to industrial production of proteins. More specifically, the invention relates to the Lupac surrogate marker, which corresponds to a fusion between luciferase and the puromycin N-acetyl transferase. The invention further relates to the use of Lupac for screening cells for high expression of a protein of interest.
    Type: Application
    Filed: December 1, 2005
    Publication date: February 7, 2008
    Inventors: Philippe Chatellard, Markus Imhof
  • Publication number: 20070258962
    Abstract: The invention relates to an expression vector comprising the promoter of the mCMV-IE2 gene, or a functional expression promoting fragment thereof, and/or an enhancer of the mCMV-IE2 gene, or a functional expression enhancing fragment thereof, wherein expression vector does not contain any complete gene of the mCMV.
    Type: Application
    Filed: March 10, 2004
    Publication date: November 8, 2007
    Applicant: Applied Research Systems ARS Holding N.V.
    Inventors: Philippe Chatellard, Markus Imhof
  • Patent number: 7292621
    Abstract: A method is provided for detecting multipath signals which includes the following steps: a total impulse response, composed essentially of multipath signals, is cross-correlated with a reference signal and a maximum of the result of the cross-correlation is determined and saved.
    Type: Grant
    Filed: May 8, 2001
    Date of Patent: November 6, 2007
    Assignee: Siemens Aktiengesellschaft
    Inventors: Reinhold Braam, Markus Imhof, Mathias Ludwig
  • Publication number: 20070134761
    Abstract: The invention relates to expression vectors comprising a DNA sequence of 146 bp capable of acting as chromatin insulator, to host cells containing such vectors, to a method of producing a desired polypeptide by using vectors containing said sequence and to the use of said DNA sequence.
    Type: Application
    Filed: October 20, 2004
    Publication date: June 14, 2007
    Applicant: Applied Research Systems ARS hOLDING N.V.
    Inventors: Phillippe Chatellard, Markus Imhof
  • Patent number: 7129062
    Abstract: The present invention relates to compositions and methods for transfecting eukaryotic cells with nucleic acid vectors. In particular, the invention relates to the uses of Matrix Attachment Region (MAR) elements to increase stable and transient transfection efficiency.
    Type: Grant
    Filed: January 28, 2002
    Date of Patent: October 31, 2006
    Assignee: Selexis SA
    Inventors: Nicolas Mermod, Monique Zahn-Zabal, Markus Imhof, Philippe Chatellard, Pierre-Alain Girod
  • Publication number: 20040151232
    Abstract: The invention relates to a method for detecting multipath signals comprising the following steps: a total impulse response (10), composed essentially of multipath signals, is cross-correlated with a reference signal and a maximum (12) of the result of said cross-correlation is determined and saved.
    Type: Application
    Filed: March 16, 2004
    Publication date: August 5, 2004
    Inventors: Reinhold Braam, Markus Imhof, Mathias Ludwig
  • Publication number: 20030087342
    Abstract: The present invention relates to compositions and methods for transfecting eukaryotic cells with nucleic acid vectors. In particular, the invention relates to the uses of MAR elements to increase stable and transient transfection efficiency.
    Type: Application
    Filed: January 28, 2002
    Publication date: May 8, 2003
    Inventors: Nicolas Mermod, Monique Zahn-Zabal, Markus Imhof, Philippe Chatellard, Pierre-Alain Girod